Up to eighty patients suffering from myeloma are expected to attend a special awareness event at The James Cook University Hospital next week, giving them the opportunity to meet and discuss their experiences of living with the blood cancer. Patients will also get the chance to find out about the wide range of support available to them in Middlesbrough, from complementary therapies to social activities.
An initial 150 patients per year are set to benefit from a new £95,000 investment in new lung surgery services at The Friarage Hospital, Northallerton. New specialist imaging equipment, increased theatre capacity for lung surgery and outpatient clinics will now be provided at the North Yorkshire hospital, benefitting patients from across Hambleton and Richmondshire and further afield, who currently face a long journey to The James Cook University Hospital in Middlesbrough.
Your health and wellbeing matters! We’re asking staff to join us on Wednesday 2 November at our first Health & Wellbeing Fair, at The James Cook University Hospital, Atrium, 9am – 2pm, to find out how to stay fit and healthy. We’ll have special guests, freebies and exclusive discount offers for all staff. Come along and find […]
Almost a third of staff at Teesside’s biggest hospital trust got their flu vaccine within 10 days of the start of a hard-hitting campaign.
A total of 29.6% of eligible staff at South Tees Hospitals NHS Foundation Trust had been vaccinated as at October 10, including 33.4% of doctors and 31.7% of support staff to clinicians.
Cardiologists at Teesside’s biggest hospital have been praised for their role in a major international study looking at the effectiveness of different treatments for patients with Ischemic Heart Disease (IHD).
The cardiothoracic team, led by Dr Mark de Belder at The James Cook University Hospital, were praised by New York University-based leaders of the ISCHEMIA trial, a major international, multicentre randomised trial researching the best way to manage the condition.
A successful project to provide intravenous (IV) antibiotics to patients with a long-term lung condition in their own homes is set to benefit dozens of others with different health conditions. The cutting-edge service improvement enterprise looked at how providing IV antibiotic therapy to patients in their own homes rather than as inpatients in hospital could improve both the patient experience and also reduce costs.